Rare cancer patients make up about half of all people fighting cancer, but they often have limited or no treatment options because rare cancer research is drastically underfunded.

Cycle for Survival raised $42 million in 2019—more than $260 million in over a decade. Every single dollar is directly allocated to rare cancer research at Memorial Sloan Kettering Cancer Center within six months of the close of fundraising.